Estrogen, through its receptors ERα (ESR1) and ERβ (ESR2), plays a pivotal role in endometrial cell proliferation, and aberrant estrogen signaling can contribute to endometrial cancer development. This evidence concerns the gene ESR2 and endometrial cancer.